TP53 and amyotrophic lateral sclerosis: In addition, in C9orf72-patient-derived fibroblasts and in vivo in a C9orf72 expansion (BAC-C9-500) mouse, models of ALS/FTD, decreasing STAU1 was sufficient to prevent p53-mediated apoptotic signaling.